Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis

PURPOSE: The purpose of this study was to compare the relative safety and efficacy of different types of phosphodiesterase type 5 inhibitors (PDE5-Is) with tamsulosin for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH) (BPH-LUTS) with or without er...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chengquan, Zhang, Jianzhong, Cai, Zhonglin, Xiong, Jian, Li, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140123/
https://www.ncbi.nlm.nih.gov/pubmed/32309423
http://dx.doi.org/10.1155/2020/1419520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140123/
https://www.ncbi.nlm.nih.gov/pubmed/32309423
http://dx.doi.org/10.1155/2020/1419520

Ejemplares similares